Minjun Chen Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

42 h-index 168 pubs 5,627 cited

Biography and Research Information

OverviewAI-generated summary

Minjun Chen's research focuses on the prediction and assessment of drug-induced liver injury (DILI) in humans, utilizing computational modeling, machine learning, and preclinical assessment methods. Chen has investigated the performance of preclinical models in predicting DILI and has explored the association between specific clinical indicators, such as elevated bilirubin and alkaline phosphatase, and the duration of recovery from DILI. Their work also involves applying natural language processing techniques, such as BERT, to drug labeling documents to classify DILI risk.

Further research includes the development and validation of computational models, particularly those employing deep learning and machine learning, for predicting liver toxicity. Chen has also examined alternative in silico methods for predicting drug and herb-induced liver injury. Collaborations include extensive work with Tsung‐Jen Liao, Kristin Ashby, Tucker A. Patterson, and Weida Tong, all from the National Center for Toxicological Research, contributing to a significant number of shared publications.

With an h-index of 43 and over 5,600 citations across 169 publications, Chen is recognized as a highly cited researcher. Their work contributes to the field of toxicology and pharmaceutical safety, aiming to improve the prediction of adverse drug reactions and enhance drug development processes.

Metrics

  • h-index: 42
  • Publications: 168
  • Citations: 5,627

Selected Publications

  • DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review (2025)
  • Machine learning and artificial intelligence methods for predicting liver toxicity (2025)
  • Contributors (2025)
  • New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? (2025)
    4 citations DOI OpenAlex
  • Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury (2025)
    9 citations DOI OpenAlex
  • Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population (2025)
    1 citation DOI OpenAlex
  • Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs (2024)
    20 citations DOI OpenAlex
  • Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury (2024)
    10 citations DOI OpenAlex
  • Automatic text classification of drug-induced liver injury using document-term matrix and XGBoost (2024)
    4 citations DOI OpenAlex
  • Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development (2024)
    11 citations DOI OpenAlex
  • Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values (2024)
    4 citations DOI OpenAlex
  • Machine Learning to Predict Drug-Induced Liver Injury and its Validation on Failed Drug Candidates in Development (2024)
  • Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects (2024)
    6 citations DOI OpenAlex
  • Computational models for predicting liver toxicity in the deep learning era (2024)
    19 citations DOI OpenAlex
  • New Alternative Methods in Drug Safety Assessment (2023)

View all publications on OpenAlex →

Collaboration Network

172 Collaborators 65 Institutions 17 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics